Literature DB >> 15665458

B1-B cells are the main antigen presenting cells in CpG-ODN-stimulated peritoneal exudate cells.

Hiromichi Bamba1, Hirohito Ishigaki, Hideaki Ishida, Kiichi Kajino, Yoshihide Fujiyama, Kazumasa Ogasawara.   

Abstract

Peritoneal exudate cells (PEC) have long been used as antigen presenting cells (APC), because they have been considered to contain mainly macrophages. However, it is still unclear specifically which cells of the peritoneal exudate function as APC. Herein, we focused on macrophages and B1-B cells of the PEC and examined their APC function and cytokine production. B1-B cells purified from PEC functioned effectively as APC after CpG-stimulation and mainly produced IL-10. In contrast, macrophages purified from PEC were not able to present incorporated antigens to T cells, despite the production of IL-12 and expression of co-stimulatory molecules after CpG stimulation. These results suggest that previously held ideas regarding the functions of the mixture of cells in the PEC need to re-evaluated. In summary, the antigen presenting function of PEC was mainly attributed to B1-B cells and immunoenhancing cytokine production was dominantly derived from peritoneal macrophages.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15665458     DOI: 10.1111/j.1348-0421.2005.tb03633.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  2 in total

Review 1.  New insights into heterogeneity of peritoneal B-1a cells.

Authors:  Hongsheng Wang; Jian-xin Lin; Peng Li; Jeff Skinner; Warren J Leonard; Herbert C Morse
Journal:  Ann N Y Acad Sci       Date:  2015-05-18       Impact factor: 5.691

2.  Adjuvant effect of killed Propionibacterium acnes on mouse peritoneal B-1 lymphocytes and their early phagocyte differentiation.

Authors:  Juliana Sekeres Mussalem; Carla Cristina Squaiella-Baptistão; Daniela Teixeira; Tatiana Mina Yendo; Felipe Garutti Thies; Ana Flavia Popi; Mario Mariano; Ieda Longo-Maugéri
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.